Mortgage Blog

Bluebird bio nets 3rd gene therapy approval since company split

Somerville's bluebird bio Inc. has won its third U.S. drug approval since splitting into two companies.

Previous Nashville's hospitality industry job market starts balancing out with diverse candidate pool
Next First-ever CRISPR drug, made by two Boston companies, is approved in the US

Related Posts

Suggested Posts